Amorphex Therapeutics
Pre-clinicalAmorphex is developing TODDD™, a patented device that corrects the many problems underermining current topical ocular pharmaceuticals.
Founded
2018
Focus
Drug Delivery
About
Amorphex is developing TODDD™, a patented device that corrects the many problems underermining current topical ocular pharmaceuticals.
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile